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Caged compoundsHistone deacetylases (HDACs) are involved in epigenetic control of the expression of various genes by
catalyzing deacetylation of e-acetylated lysine residues. Here, we report the design, synthesis and eval-
uation of the (7-diethylaminocoumarin-4-yl)methyl ester of suberoylanilide hydroxamic acid (AC-
SAHA) as a caged HDAC inhibitor, which releases the known pan-HDAC inhibitor SAHA upon cleavage
of the photolabile (7-diethylaminocoumarin-4-yl)methyl protecting group in response to photoirradia-
tion. A key advantage of AC-SAHA is that the caged derivative itself shows essentially no HDAC-inhibitory
activity. Upon photoirradiation, AC-SAHA decomposes to SAHA and a 7-diethylaminocoumarin deriva-
tive, together with some minor products. We confirmed that AC-SAHA inhibits HDAC in response to pho-
toirradiation in vitro by means of chemiluminescence assay. AC-SAHA also showed photoinduced
inhibition of proliferation of human colon cancer cell line HCT116, as determined by MTT assay. Thus,
AC-SAHA should be a useful tool for spatiotemporally controlled inhibition of HDAC activity, as well as
a candidate chemotherapeutic reagent for human colon cancer.
 2016 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Histone deacetylases (HDACs) catalyze deacetylation of e-acety-
lated lysine residues,1 and play a role in epigenetic control of gene
expression by reversible acetylation of histone proteins, in con-
junction with histone acetyltransferases (HATs).2 HDACs are highly
expressed in various diseases, including cancers,3 nervous dis-
eases,4 and inflammatory diseases,5 and HDAC inhibitors enhance
the generation of induced pluripotent stem cells (iPS cells).6 Thus,
inhibitors of HDACs are candidate chemotherapeutic drugs and
chemical tools for regeneration therapies. However, HDACs are
localized in various organelles in cells, not only in the nucleus,
and they deacetylate various proteins other than histones,7 so that
sophisticated technology for precise spatiotemporal control of
HDAC activity is required to investigate the importance of HDAC
localization and timing of HDAC upregulation. Recently, Feringa
and co-workers reported light-controlled HDAC inhibitors contain-
ing an azobenzene moiety, which change their cis/trans structure
in response to light, resulting in a reversible change of their
pharmacological activity.8 However, both conformations showedat least moderate inhibition due to their bare hydroxamate groups,
so that precise off/on control of inhibition is not possible. Here, we
achieved tight photocontrol of HDAC-inhibitory activity by caging
the hydroxamate group with a photolabile protecting group (PPG).
To develop a photocaged HDAC inhibitor, we focused on the
HDAC pan-inhibitor suberoylanilide hydroxamic acid (Fig. 1, SAHA;
1),9 which is clinically used to treat cutaneous T-cell lymphoma. In
general, a critical structure of HDAC inhibitors is a zinc-binding
group (ZBG), which strongly binds to Zn2+ in the active site of
HDAC.10 The ZBG of SAHA is a hydroxamate group.1 Our design
strategy was based on the idea that this hydroxamate moiety could
be blocked with a photolabile protecting group (PPG), affording an
inactive compound. Light-induced deprotection would remove the
PPG, resulting in strong HDAC inhibition. As the PPG, we focused
on the (7-diethylaminocoumarin-4-yl)methyl group, which shows
strong absorbance around 400 nm, is efficiently photodecomposed,
and is easily synthesizable.11 Therefore, we synthesized AC-SAHA
(2) as a photocaged HDAC inhibitor, as shown in Scheme 1. Briefly,
(7-diethylaminocoumarin-4-yl)methyl bromide 312 was converted
to aminoxylated compound 4, which was deprotected with HCl to
obtain 5. Condensation reaction with suberanilic acid afforded
AC-SAHA, whose structure was determined by NMR, MS, and
elemental analyses.
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Figure 1. Protection of SAHA with a photo-labile protecting group to enable photocontrol of its HDAC-inhibitory activity.
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Scheme 1. Synthetic scheme of AC-SAHA.
2790 N. Ieda et al. / Bioorg. Med. Chem. 24 (2016) 2789–2793The UV–Vis spectrum of a solution of AC-SAHA in Tris buffer
showed strong absorption around 400 nm derived from the cou-
marinyl moiety (kmax = 398 nm, e398 nm = 1.24  104 M1 s1), as
shown in Figure 2. Therefore, we decided to use a Xe lamp source
equipped with a 400–430 nm band pass filter.
We next examined the photodecomposition products of AC-
SAHA by means of HPLC analysis. As shown in Figure 3, a decrease
of the peak intensity of AC-SAHA was accompanied by an increase
of SAHA upon irradiation (400–430 nm, 66 mW/cm2) of a solution
of AC-SAHA in Tris buffer (pH 7.5, DMSO 20%). It should be noted
that several minor peaks appeared after irradiation, in addition
to SAHA and 7-diethylamino-3-hydroxymethylcoumarin; one
was identified as suberanilic acid, but the others were not
identified.
SAHA formation was examined as a function of photoirradiation
time by means of HPLC. As shown in Figure 4, photoinduced AC-
SAHA decomposition and SAHA formation were both dependent
on irradiation time. After complete photodecomposition, 200 lM
AC-SAHA was converted into 54 lM SAHA. We considered that
the relatively low yield of SAHA was related to the high pKa value0
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Figure 2. Absorbance UV–Vis spectrum of a solution of AC-SAHA (50 lM) in
200 mM Tris buffer (pH 7.5).
Figure 3. HPLC chromatograms monitored at 254 nm: (a) a solution of AC-SAHA
(500 lM); (b) a solution of SAHA (500 lM); (c) a solution of AC-SAHA (500 lM) in
Tris buffer (200 mM, pH 7.5, DMSO 20%) after irradiation (400–430 nm, 66 mW/
cm2) for 10 min. Arrows indicate identified peaks.
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Figure 4. Quantitative analysis of AC-SAHA and photo-uncaged SAHA. A solution of
AC-SAHA (20 lM) in Tris buffer (200 mM, pH 7.5, DMSO 20%) was irradiated at
400–430 nm (66 mW/cm2).
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Figure 5. HDACs activity assay with HDAC-Glo I/II assay kit (Promega). A solution
of AC-SAHA (1 lM) and HDACs (HeLa cell nuclear extract) in HDAC-Glo I/II buffer
(DMSO 0.5%) was irradiated at 400–430 nm (66 mW/cm2).
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Figure 6. Cell growth inhibition assay was performed using a CellTiter-Glo
Luminescent Cell Viability assay kit (G7570, Promega Corporation). HCT116 cells
were treated with AC-SAHA (10 lM or 30 lM, 0.5% DMSO, Dulbecco’s phosphate-
buffered saline) and irradiated at 400–430 nm light for the indicated time.
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other photo-decomposition pathways, such as suberanilic acid
formation.
Next, the quantum yield of AC-SAHA was determined by using a
potassium ferrioxalate chemical actinometer (Table 1).13 In
response to 405 nm light irradiation, the photodecomposition
quantum yield (UP) was calculated as 4.49  103, and the quan-
tum yield of SAHA release (USAHA) was 1.53  103. Photolytic
cross-section (eU) is an important factor to estimate the efficiency
of the uncaging reaction. In the case of AC-SAHA, the value of e405
nmUSAHA was calculated to be 19, which is comparable with the
values reported for o-nitrobenzyl ester caged compounds
(eU = 15–70).14
To evaluate the HDAC-inhibitory activity of AC-SAHA, we used
the luminescence-based HDAC-Glo I/II assay kit (Promega). As
shown in Figure 5, AC-SAHA showed HDAC-inhibitory activity in
an irradiation-time-dependent manner; we confirmed that irradia-
tion alone did not inhibit HDAC. Notably, an unirradiated solution
of AC-SAHA did not show any HDAC-inhibitory activity at all, in
marked contrast to previously reported light-controlled HDAC
inhibitors, which show partial inhibitory activity even in their ‘in-
active’ conformation. The photodecomposition products 7-diethy-
lamino-4-hydroxymethylcoumarin and suberanilic acid (0.5 lM)
did not inhibit HDAC (data not shown). Although other unidenti-
fied photoproducts were formed from AC-SAHA, they did not
appear to influence the inhibitory activity of the released SAHA,
though we cannot rule out some contribution to the inhibitory
effect.
In order to examine the utility of AC-SAHA in the cellular envi-
ronment, we conducted cell growth inhibition assay with HCT116
cells, using the CellTiter-Glo Luminescent Cell Viability kit (Pro-
mega). HCT116 cells were incubated with AC-SAHA for 3 hr. At var-
ious time points, the cells were irradiated for 1, 3, and 10 min, then
incubated for a further 48 h. Assay reagent was added to the cells,
and the chemiluminescence was recorded with a plate reader. As
shown in Figure 6, cell growth was inhibited by the combination
of AC-SAHA and light irradiation. The inhibition was found to be
dependent on AC-SAHA concentration and irradiation time. Thus,Table 1
Values of quantum yield and photolytic cross-section of AC-SAHA
Photodecomposition SAHA release
Extinction coefficient e405 nm
(M1 cm1)
1.21  104
Quantum yield U 0.00449 ± 0.00019 0.00153 ± 0.00021
Cross-section e405 mmU 54 ± 2.3 19 ± 2.5AC-SAHA might be available as a novel photodynamic therapy
reagent.
Very recently, two independent works were reported to photo-
control of the activity of HDAC inhibitors.15,16 They are interesting
and emphasize the importance of the photocontrol of HDAC inhibi-
tion, in addition to our work, but one of those adopted photoiso-
merization of azobenzene moiety to control inhibitory activity15,
which may result in the un-sharp photoresponse due to incom-
plete isomerization and possible rapid equilibrium of the azoben-
zene moiety. The other one employs the ortho-nitrobenzyl
moiety for caging group16, but it is mainly uncaged by UV light,
which would be harmful to the cells. Our caged SAHA adopting a
coumarin derivative which can be uncaged by visible range of light
and once uncaged the inhibitory effect would be sharply activated.
In conclusion, we synthesized and evaluated a novel caged
HDAC inhibitor, AC-SAHA. The inhibitory activity of SAHA towards
HDACs was completely suppressed by the coumarinyl group, while
photoirradiation released the coumarinyl group from the main
active moiety, hydroxamate, releasing HDAC inhibitor SAHA in a
precisely controlled manner. Although unidentified photodecom-
position products were formed in addition to SAHA and hydrox-
ymethylcoumarin, they did not appear to show HDAC-inhibitory
activity, and photo-released SAHA was suggested to be the main
inhibitory component. Thus, AC-SAHA is able to control HDAC
activity in response to light irradiation. We also confirmed that it
2792 N. Ieda et al. / Bioorg. Med. Chem. 24 (2016) 2789–2793could similarly inhibit cell growth of HCT116 cells. AC-SAHA is
expected to be a useful chemical tool to investigate epigenetic
events, as well as a candidate photodynamic therapy reagent.2. Experimental
2.1. General methods
Melting points were determined using a Yanagimoto micro
melting point apparatus or a Büchi 545 melting point apparatus
and were left uncorrected. Proton nuclear magnetic resonance
spectra (1H NMR) and carbon nuclear magnetic resonance spectra
(13C NMR) were recorded on a JEOL JNM-LA500, JEOL JNM-A500,
Varian VNMRS 500 or Bruker AVANCE600 spectrometer in the indi-
cated solvent. Chemical shifts (d) were reported in parts per million
relative to the internal standard, tetramethylsilane. Elemental
analysis was performed with a Yanaco CHN CORDER NT-5 ana-
lyzer, and all values were within ±0.4% of the calculated values
(>95% purity). High-resolution mass spectra (HRMS) and fast atom
bombardment (FAB) mass spectra were recorded on a JEOL JMS-
SX102A mass spectrometer. GC-MS analyses were performed on
a Shimadzu GCMS-QP2010. Analytical HPLC was performed with
a Shimadzu instrument equipped with an ODS-3 column
(4.6  150 mm, GL Science). Ultraviolet–visible-light spectra were
recorded on an Agilent 8453 spectrophotometer. Reagents and sol-
vents were purchased from Aldrich, Tokyo Chemical Industry,
Wako Pure Chemical Industries, Kanto Kagaku, and Junsei Kagaku,
and were used without purification. Flash column chromatography
was performed using Silica Gel 60 (particle size 0.046–0.063 mm)
supplied by Taiko-Shoji. Photoirradiation was performed with the
light source of an Asahi Spectra MAX-302 irradiation apparatus.
2.2. Preparation of 4
Sodium hydride (60% in mineral oil; 14 mg, 0.35 mmol,
1.5 equiv) was added to an ice-cold solution of N-Boc hydroxy-
lamine (42 mg, 0.32 mmol, 1.4 equiv) in anhydrous THF (2 mL)
under an N2 atmosphere. The mixture was allowed to warm to
room temperature and stirring was continued for 2 h, then it was
cooled to 0 C again. A solution of 3 (71 mg, 0.23 mmol) and TBAI
(cat.) in anhydrous THF (1 mL) was added dropwise to the resul-
tant suspension on an ice-water bath. The mixture was stirred at
0 C overnight and then poured into ice water and extracted with
AcOEt. The combined extracts were dried over Na2SO4, filtered
and concentrated. The residue was purified by silica gel flash col-
umn chromatography (n-hexane/AcOEt = 4/1) to give 78 mg
(0.21 mmol, 93%) of 4 as an orange solid: 1H NMR (CDCl3,
500 MHz, d; ppm) 7.59 (1H, d, J = 9.1 Hz), 7.49 (1H, s), 6.60 (1H,
dd, J = 9.0 Hz, J = 2.5 Hz), 6.51 (1H, d, J = 2.4 Hz), 6.14 (1H, s), 4.98
(2H, s), 3.42 (4H, q, J = 7.0 Hz), 1.49 (9H, s), 1.22 (6H, t, J = 7.1 Hz).
2.3. Preparation of 5
To a solution of 4 (114 mg, 0.315 mmol) in CH2Cl2 (3 mL) was
added 4 N HCl/AcOEt (1.5 mL). The reaction mixture was stirred
for 2 h at room temperature, then concentrated by evaporation in
vacuo to give 88 mg (0.29 mmol, 93%) of 5 as a yellow solid: 1H
NMR (DMSO-d6, 500 MHz, d; ppm) 10.3 (2H, s), 7.55 (1H, d,
J = 9.1 Hz), 6.73 (1H, d, J = 9.0 Hz), 6.57 (1H, s), 6.10 (1H, s), 5.23
(2H, s), 3.44 (4H, q, J = 7.2 Hz), 1.12 (6H, t, J = 7.0 Hz).
2.4. Preparation of AC-SAHA
A solution of DIPEA (155 lL, 0.887 mmol, 2.2 equiv), suberanilic
acid (114 mg, 0.457 mmol, 1.1 equiv) and COMU (228 mg,0.531 mmol, 1.3 equiv) in DMF (1.5 mL) was stirring under an N2
atmosphere. The reaction mixture was stirred at room temperature
for 30 min, at which point a solution of 5 (120 mg, 0.402 mmol)
and DIPEA (77 lL, 0.44 mmol, 1.1 equiv) in DMF (1.5 mL) was
added. Stirring was continued for 1 h at room temperature and
the reaction was quenched by addition of saturated aqueous NH4-
Cl. The aqueous layer was extracted with AcOEt. The combined
extracts were dried over Na2SO4, filtered and evaporated. The pre-
cipitate was collected by filtration and washed with n-hexane to
give 93 mg (0.19 mmol, 47%) of AC-SAHA as a yellow solid: 1H
NMR (DMSO-d6, 500 MHz, d; ppm) 11.2 (1H, s), 9.84 (1H, s), 7.70
(1H, d, J = 9.1 Hz), 7.58 (2H, d, J = 8.0 Hz), 7.27 (2H, t, J = 7.2 Hz),
7.01 (1H, t, J = 7.4 Hz), 6.69 (1H, dd, J = 9.1 Hz, J = 2.4 Hz), 6.53
(1H, ds, J = 2.4 Hz), 6.10 (1H, s), 4.94 (2H, s), 3.42 (4H, q,
J = 7.0 Hz), 2.28 (2H, t, J = 7.3 Hz), 1.98 (2H, t, J = 7.3 Hz), 1.59–
1.55 (2H, m), 1.53–1.49 (2H, m), 1.32–1.25 (4H, m), 1.12 (6H, t,
J = 7.0 Hz); MS (FAB) m/z: 494 [M+H]; Anal. Calcd for C28H35N3O5-
1/2 H2O: C, 66.91; H, 7.22; N, 8.36. Found: C, 65.94; H, 7.33; N,
8.62.
2.5. Measurement of absorbance spectra of AC-SAHA
A solution of 5.0 mM AC-SAHA (10 lL) in DMSO was diluted
with DMSO (190 lL) and 200 mM Tris–HCl buffer pH 7.5
(800 lL) to prepare sample solutions (50 lM, 20% DMSO,
200 mM Tris–HCl buffer, pH 7.5). Blank solution (MilliQ containing
20% DMSO) was transferred into a cuvette to measure the blank
absorption, and then a sample solution was transferred into a cuv-
ette to measure the absorption spectrum. UV/vis spectra were
recorded on an Agilent 8453 spectrometer at room temperature.
2.6. HPLC analysis of uncaging products
A solution of 5 mM AC-SAHA (100 lL) in DMSO was diluted
with DMSO (100 lL) and 200 mM Tris–HCl buffer pH 7.5
(800 lL) to prepare sample solutions (500 lM, 20% DMSO,
200 mM Tris–HCl buffer, pH 7.5). A solution of 5.0 mM SAHA
(100 lL) in DMSO was diluted with DMSO (100 lL) and 200 mM
Tris–HCl buffer pH 7.5 (800 lL) to prepare standard sample solu-
tions (500 lM, 20% DMSO, 200 mM Tris–HCl buffer, pH 7.5). A
180 lL aliquot was placed in a 4 mL cuvette and photoirradiated
with visible light (400–430 nm) through a ND filter at room tem-
perature for 0.5, 1.0, 3.0, 6.0, 10 min using a MAX-302 light source
(Asahi Spectra, Tokyo, 300 W Xe lamp), whose lens was placed at a
distance of 10.0 cm from the table. Light intensity was set at
66 mW/cm2. After photoirradiation, the resulting solution was
loaded onto a Senshu Pak C18 column (5 lm; 150  4.6 mm) fitted
on a Shimadzu HPLC system, and the eluates were monitored with
a photodiode array detector. Standard solutions were loaded and
monitored in the same way as the sample solutions. Injection vol-
ume was 20 lL and flow rate was 1.0 mL/min. All chromatograms
were detected at 254 nm. Milli-Q water containing 0.1% TFA (A)
and MeCN containing 0.1% TFA (B) were used as developing sol-
vents. Gradient conditions were as follows: 0 min, A 70% and B
30%? 15 min, A 35% and B 65%? 18 min, A 35% and B 65%?
20 min, A 70% and B 30%.
2.7. Enzyme inhibition assay
HDAC-activity assay was performed using an HDAC-GloTM I/II
assay kit (G6430, Promega Corporation). A solution of AC-SAHA
(2 lM, 2% DMSO, HDAC-GloTM I/II Buffer) was prepared. Sample
solution (25 lL) was added to 96-well plates, and 25 lL of
HDAC-GloTMI/II Buffer containing 1% DMSO was added to wells as
controls (no sample) and blanks (no enzyme). The HDAC enzyme
source was diluted in HDAC-GloTMI/II Buffer (HeLa nuclear extract
N. Ieda et al. / Bioorg. Med. Chem. 24 (2016) 2789–2793 27931:3000 dilution). Aliquots of 25 lL of the HDAC enzyme dilutions
were added to sample and control wells, and HDAC-GloTMI/II Buffer
only was added to blank wells. The plate was mixed at room tem-
perature by hitting the corner of the plate and shaking several
times. The plates were irradiated with 400–430 nm light for 1.0,
3.0, 6.0, and 10.0 min. These enzyme/inhibitor mixtures were incu-
bated at room temperature for 60 min. The HDAC-GloTMI/II Reagent
was prepared as follows: add 10 mL of HDAC-GloTMI/II Buffer to the
HDAC-GloTMI/II Substrate, then mix, and add 10 lL of Developer
Reagent to form the HDAC-GloTMI/II Reagent, then mix, and add
50 lL of the HDAC-GloTMI/II Reagent to each assay well. The plate
was mixed at room temperature by hitting the corner of the plate
and shaking several times, and then incubated at room tempera-
ture for 30 min to stabilize the luminescence signal. The chemilu-
minescence at 562 nm of the wells was measured with a
luminometric reader and the enzyme activity was calculated from
the luminescence readings of inhibited wells relative to those of
control wells.
2.8. Cell growth inhibition assay
Cell growth inhibition assay was performed using a CellTiter-
Glo Luminescent Cell Viability assay kit (G7570, Promega Corpora-
tion). HCT116 cells were plated on a 96-well plate at an initial den-
sity of 5000 cells/well with 50 lL of the culture medium and
allowed to attach overnight. A solution (50 lL) of AC-SAHA
(20 lM or 60 lM, 1% DMSO, McCoy’s 5A culture medium) was
added to the plate and it was incubated for 3 h. Each wells of the
plate were washed with 50 lL of D-PBS, and the medium was
replaced with 100 lL of D-PBS, then the cells were irradiated with
400–430 nm light for 1.0, 3.0, or 10.0 min. The dishes were
refreshed with 100 lL of the culture medium and incubated for
48 h. The CellTiter-Glo Reagent was prepared by mixing 10 mL of
CellTiter-Glo Buffer and CellTiter-Glo Substrate, and 50 lL was
added to each assay well. The plate was mixed for 2 min on an
orbital shaker to induce cell lysis, and incubated at room tempera-
ture for 10 min to stabilize the luminescence signal. The chemilu-
minescence at 562 nm of the wells was measured on a
luminometric reader and the % cell viability was calculated from
the luminescence readings of inhibited wells relative to those of
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